Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
adult stem cells
Biotech
Gamida accepts sale to investment firm to survive
With no luck finding a partner for Omisirge, Gamida has accepted the only way to survive is for its principal lender to acquire the company.
James Waldron
Mar 27, 2024 9:53am
Mount Sinai unveils 3-branch regenerative medicine institute
Apr 24, 2023 3:25pm
AnaBios acquires cell culture media group for undisclosed price
Apr 12, 2023 12:32pm
Talaris restarts trial after assurance regarding patient death
Oct 20, 2022 10:05am
Modeling embryonic circulation, team produces blood stem cells
Sep 15, 2022 7:15am
Fat could hold key to stem cell treatment for Parkinson's
May 31, 2022 7:30am
